July 26, 2018Press Releases
AUSTIN, Texas & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Jul. 26, 2018– Genprex, Inc. (NASDAQ:GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, has entered a Sponsored Research Agreement (“Agreement”) with The University of Texas MD Anderson Cancer Center under which Genprexwill sponsor a pre-clinical study, entitled “A Novel Therapeutic Approach for the Treatment […]